ORK Orkla ASA

Orkla ASA: Strong growth for Orkla’s brands

Orkla ASA: Strong growth for Orkla’s brands

Orkla’s operating profit (EBIT adj.) increased by 8.7% to NOK 1,205 million in the second quarter of 2020. Operating revenues rose by 5.3% to NOK 11,099 million. Adjusted earnings per share increased in the quarter by 18% to NOK 1.10.



Orkla’s Branded Consumer Goods operations, including Headquarters, had a 16% improvement in operating profit. The improvement is a result of factors including cost-cutting measures related to the coronavirus pandemic, productivity improvements and positive currency translation effects.

Four out of five business areas had a marked improvement in operating profit in the second quarter, compared with the same period of 2019: Orkla Consumer Investments (+46%), Orkla Care (+27%), Orkla Confectionery & Snacks (+26%) and Orkla Foods (+22%). Due to lockdowns in several markets and government-imposed restrictions, Orkla Food Ingredients saw a 48% decline in operating profit.

Orkla’s Branded Consumer Goods operations had turnover growth of 6.2%, primarily due to currency fluctuations and acquisitions of companies. Organic growth was -3.8% in the second quarter. Orkla had good sales growth in the grocery market, but a considerable decline in sales to the out-of-home sector.

“We can look back on a half-year marked by the biggest ever peacetime crisis. In March, there was extensive stockpiling in grocery stores. After a slow start to the second quarter, volumes have picked up again. It looks as though consumers turn to well-known, familiar brands in times of crisis like the one we are currently experiencing. Outside the grocery sector, however, our companies have seen a substantial reduction in demand due to various restrictions imposed by the government. Now that society is gradually opening up again, we have also seen an improvement in out-of-home demand,” says Orkla President and CEO Jaan Ivar Semlitsch.

“As a supplier of food, household cleaning and personal hygiene products, we at Orkla have a responsibility to society to ensure that our products are available. It’s therefore gratifying to see that we have succeeded in maintaining close to normal supply chain operations during the coronavirus pandemic, while also fulfilling our top priority of protecting the health and safety of our employees,” he adds.

Orkla has also taken a number of structural actions:

  • Orkla Wound Care has signed and completed an agreement to buy the shares in Norgesplaster. The company holds good positions in the wound care and first aid equjpment markets.
  • Orkla Foods Sverige has signed and completed an agreement with PepsiCo, Inc. to purchase the Havrefras brand, including Rug Fras and Mini Fras. The brands hold strong positions in Scandinavia in healthy breakfast cereals.
  • Orkla Foods Norge has signed an agreement to sell SaritaS, Vestlandslefsa and Li-Klenning. The purpose of the disposals is to streamline the portfolio and concentrate the business on selected core areas.
  • It has been decided to wind up the Swedish business in Pierre Robert Group, and activity has gradually been reduced in the first half-year.

Hydro Power’s operating profit amounted to NOK -19 million, compared with NOK 69 million in the second quarter of 2019. The decline in profit was due to substantially lower power prices.

Profit from associates increased by 37% to NOK 248 million. The improvement is mainly due to good profit growth and margin performance, as well as positive currency translation effects, in Jotun.

Orkla’s profit before tax rose by 2% to NOK 1,200 million in the second quarter.

              

Orkla ASA

Oslo, 13 July 2020

Ref.:

Group Director Corporate Communications and Corporate Affairs

Håkon Mageli

Mobile:  828

SVP Investor Relations

Thomas Ljungqvist

Mobile: +47 482 59 618



An Excel spreadsheet with key figures may be found at .

This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Attachments

EN
13/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Orkla ASA

Ole Martin Westgaard
  • Ole Martin Westgaard

Orkla (Hold, TP: NOK81.00) - From gross margin to opex focus

We are slightly positive ahead of the Q1 results (due at 07:00 CET on 3 May), expecting adj. EBIT 6% above consensus on marginally higher margins in the consolidated portfolio companies (CPC). We reiterate our HOLD and NOK81 target price.

Orkla ASA: 1 director

A director at Orkla ASA bought 12,930 shares at 76.300NOK and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

Ole Martin Westgaard
  • Ole Martin Westgaard

Orkla (Hold, TP: NOK81.00) - Early signs of margin recovery

Q4 disappointed; however, encouragingly, we believe there were early signs that the negative volume trend looks to be easing and margins seem to have troughed. We reiterate our HOLD, but have lowered our target price to NOK81 (85) on our negative estimate revisions.

Ole Martin Westgaard
  • Ole Martin Westgaard

Orkla (Hold, TP: NOK85.00) - Weak Q4 with an improved outlook

We consider this a soft report, with figures below expectations due to weaker than expected margins and slightly positive outlook comments. We expect a 1–3% negative revision to consensus 2024 adj. EBIT on the back of the report and believe a slight negative share price reaction is warranted.

Ole Martin Westgaard
  • Ole Martin Westgaard

Orkla (Hold, TP: NOK85.00) - Set for CPC margin recovery in Q4

We are positive ahead of the Q4 results (due at 07:00 CET on 8 February), expecting adj. EBIT 19% above consensus, largely reflecting a margin recovery in CPC and continued strong price-driven organic growth. We reiterate our HOLD and NOK85 target price.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch